Gregorio Soto-Campos
Overview
Explore the profile of Gregorio Soto-Campos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alvarez-Gutierrez F, Casas-Maldonado F, Soto-Campos G
Arch Bronconeumol
. 2024 Oct;
PMID: 39428316
No abstract available.
2.
Plaza V, Blanco M, Ferreira J, Garcia G, Morete A, Quirce S, et al.
Open Respir Arch
. 2024 Oct;
6(4):100356.
PMID: 39351170
No abstract available.
3.
Alvarez-Gutierrez F, Casas-Maldonado F, Soto-Campos G, Blanco-Aparicio M, Delgado J, Galo A, et al.
Arch Bronconeumol
. 2024 May;
60(8):503-509.
PMID: 38697903
The concept of "remission" in asthma has been around for a long time and it has been a controversial topic. Despite the attempts of some studies to characterize this entity,...
4.
Alvarez-Gutierrez F, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, Gonzalez-Barcala F, Carretero-Gracia J, et al.
Open Respir Arch
. 2023 Jul;
4(3):100192.
PMID: 37496585
Severe asthma is a heterogeneous syndrome with several clinical variants and often represents a complex disease requiring a specialized and multidisciplinary approach, as well as the use of multiple drugs....
5.
Alvarez-Gutierrez F, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, Gonzalez-Barcala F, Carretero-Gracia J, et al.
Arch Bronconeumol
. 2022 Oct;
59(3):190-192.
PMID: 36243640
No abstract available.
6.
Casas-Maldonado F, Alvarez-Gutierrez F, Blanco-Aparicio M, Domingo-Ribas C, Cisneros-Serrano C, Soto-Campos G, et al.
J Asthma
. 2021 Sep;
59(10):1997-2007.
PMID: 34503370
Background: Monoclonal antibodies (mABs) have become available to treat more efficiently patients with severe uncontrolled asthma (SUA). However, the use of mABs is lower than expected given the prevalence of...